Marshall Wace, LLP Organigram Holdings Inc. Transaction History

Marshall Wace, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.87 - $1.24 $37,758 - $53,816	43,400 New	43,400 $38,000
Q1 2022 May 16, 2022	SELL	$1.3 - $1.83 $40,522 - $57,042	-31,171 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.75 - $2.48 $54,549 - $77,304	31,171 New	31,171 $54,000
Q2 2021 Aug 13, 2021	SELL	$2.34 - $3.49 $566,249 - $844,534	-241,987 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.46 - $6.0 $353,301 - $1.45 Million	241,987 New	241,987 $837,000
Q4 2019 Feb 14, 2020	SELL	$2.06 - $3.77 $906,338 - $1.66 Million	-439,970 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.44 - $7.08 $1.51 Million - $3.11 Million	439,970 New	439,970 $1.51 Million

7.38M

Ticker OGI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 313,708,000
Market Cap $486M
Description
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.